The impact of the hypoxia‐VEGF‐vascular permeability on COVID‐19‐infected patients
The impact of the hypoxia‐VEGF‐vascular permeability on COVID‐19‐infected patients
About this item
Full title
Author / Creator
Publisher
China: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
China: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Effective treatment of patients with severe COVID‐19 to reduce mortality remains one of the most challenging medical issues in controlling unpredictable emergencies caused by the global pandemics. Unfortunately, such effective therapies are not available at this time of writing. In this article, I discuss the possibility of repurposing clinically a...
Alternative Titles
Full title
The impact of the hypoxia‐VEGF‐vascular permeability on COVID‐19‐infected patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_50c34bfb6ed849449d1007cc1c6e15a5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_50c34bfb6ed849449d1007cc1c6e15a5
Other Identifiers
ISSN
2766-8509,2766-2098
E-ISSN
2766-2098
DOI
10.1002/EXP.20210051
